VAERS Explorer
Back to explore

Report #2844096

Received Jun 5, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
41 yrs
State
GA
Recovered
Unknown
Vaccinated
Jun 2, 2025
Onset
Jun 2, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
MMRMEASLES + MUMPS + RUBELLA (PRIORIX)GLAXOSMITHKLINE BIOLOGICALSUNK32YB4—

Symptoms (1)

Product preparation issue

Symptom narrative

Incorrect Preparation/nurses administered just the diluent portion; Incorrect Preparation/nurses administered just the diluent portion; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 41-year-old female patient who received MMR (Priorix) (batch number 32YB4, expiry date 01-DEC-2026) for prophylaxis. On 02-JUN-2025, the patient received Priorix. On 02-JUN-2025, an unknown time after receiving Priorix, the patient experienced inappropriate preparation of medication (Verbatim: Incorrect Preparation/nurses administered just the diluent portion) and inappropriate dose of vaccine administered (Verbatim: Incorrect Preparation/nurses administered just the diluent portion). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 03-JUN-2025 The reporter had one of our nurses administered just the diluent portion, missed to combine the vial, the powder and just wanted to know when they should try to re-administer the vaccine, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter consented to follow up.